Los casados se aburren de estar en el sofa con sus parejas
A los solteros les puede parecer que no hay nada mas aburrido que pasar el sabado por la noche tendido en el sofa con la mujer que ves todos los dias. Pero esa, precisamente, es una de las cosas buenas que tiene una relacion. "Esas situaciones se dan cuando se ha creado un vinculo emocional y ya no es necesaria la seduccion permanente. Uno puede estar relajado, sin tener que brindar siempre su mejor cara y eso ayuda a conseguir el equilibrio psicologicos y aporta una sensacion de comodidad", asegura Freixa.
Silagra
Sunday, September 19, 2010
Wednesday, September 15, 2010
Purchasing four popular branded drugs
Drug companies are known for marking up their branded drugs by ridiculous margins. Certain drugs are sold for hundreds, even thousands, of times more than they actually cost to produce. Researchers from Erasmus University Rotterdam recently conducted a study showing that millions of people would be reduced to poverty status if they had to pay full price for some of today's most common drugs.
Published in the journal Public Library of Science Medicine (PLoS), the study evaluated the status of low- and middle-income people from 16 different countries to see how purchasing four popular branded drugs would affect their incomes and living statuses. These drugs included salbutamol, an inhaler used for asthma, glibenclamide, a diabetes drug, atenolol, a high blood pressure beta-blocker, and amoxicillin, an common antibiotic.
Purchasing Daonil, a branded version of glibenclamide made by Sanofi-Aventis, would increase the poverty rate in Yemen by 22 percent, for instance. And in Nigeria, Amoxil, an amoxicillin drug produced by GlaxoSmithKline, would impoverish an additional 23 percent of the population.
Drug companies typically own the patents on their drugs for about 20 years. Until the patent expires, no other company is allowed to legally produce generic varieties of the same drug. So the original drug company that produces a drug can charge whatever it wishes for that drug because it holds a monopoly on it.
Many have criticized the drug patent system because they say it bars lower income populations from obtaining essential medicines. Others say the U.S. Food and Drug Administration (FDA) is to blame because it only approves patented drugs as official treatments for health conditions, essentially raising the overall cost of medicine while reducing the quality of it.
Published in the journal Public Library of Science Medicine (PLoS), the study evaluated the status of low- and middle-income people from 16 different countries to see how purchasing four popular branded drugs would affect their incomes and living statuses. These drugs included salbutamol, an inhaler used for asthma, glibenclamide, a diabetes drug, atenolol, a high blood pressure beta-blocker, and amoxicillin, an common antibiotic.
Purchasing Daonil, a branded version of glibenclamide made by Sanofi-Aventis, would increase the poverty rate in Yemen by 22 percent, for instance. And in Nigeria, Amoxil, an amoxicillin drug produced by GlaxoSmithKline, would impoverish an additional 23 percent of the population.
Drug companies typically own the patents on their drugs for about 20 years. Until the patent expires, no other company is allowed to legally produce generic varieties of the same drug. So the original drug company that produces a drug can charge whatever it wishes for that drug because it holds a monopoly on it.
Many have criticized the drug patent system because they say it bars lower income populations from obtaining essential medicines. Others say the U.S. Food and Drug Administration (FDA) is to blame because it only approves patented drugs as official treatments for health conditions, essentially raising the overall cost of medicine while reducing the quality of it.
Subscribe to:
Posts (Atom)